Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
20
ICLR Quote, Financials, Valuation and Earnings
Last price:
$99.70
Seasonality move
:
-1.15%
Day range:
$96.83 - $100.83
52-week range:
$66.57 - $211.00
Dividend yield:
0%
P/E ratio:
13.48x
P/S ratio:
0.99x
P/B ratio:
0.82x
Volume:
1.6M
Avg. volume:
2.6M
1-year change:
-50.6%
Market cap:
$7.6B
Revenue:
$8.3B
EPS (TTM):
$7.40
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ICLR
ICON plc
|
$2B | $3.27 | -0.99% | 62.71% | $157.71 |
|
FONR
FONAR Corp.
|
-- | -- | -- | -- | -- |
|
FUNI
Hypha Labs, Inc.
|
-- | -- | -- | -- | -- |
|
IDXG
Interpace Biosciences, Inc.
|
-- | -- | -- | -- | -- |
|
TMO
Thermo Fisher Scientific, Inc.
|
$11.9B | $6.45 | 4.95% | 33.13% | $666.46 |
|
XWEL
XWELL, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ICLR
ICON plc
|
$99.70 | $157.71 | $7.6B | 13.48x | $0.00 | 0% | 0.99x |
|
FONR
FONAR Corp.
|
$18.60 | -- | $117.1M | 16.52x | $0.00 | 0% | 1.12x |
|
FUNI
Hypha Labs, Inc.
|
$0.03 | -- | $5.1M | 4.88x | $0.00 | 0% | 1.16x |
|
IDXG
Interpace Biosciences, Inc.
|
$1.85 | -- | $51.2M | 6.88x | $0.00 | 0% | 0.71x |
|
TMO
Thermo Fisher Scientific, Inc.
|
$510.93 | $666.46 | $192B | 28.80x | $0.43 | 0.34% | 4.33x |
|
XWEL
XWELL, Inc.
|
$0.38 | -- | $2.2M | -- | $0.00 | 0% | 0.07x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ICLR
ICON plc
|
27.67% | 0.687 | 26.73% | 0.98x |
|
FONR
FONAR Corp.
|
18.36% | 1.180 | 38.72% | 11.15x |
|
FUNI
Hypha Labs, Inc.
|
-290.87% | 1.421 | 28.13% | 0.03x |
|
IDXG
Interpace Biosciences, Inc.
|
115.19% | 2.171 | 56.7% | 1.24x |
|
TMO
Thermo Fisher Scientific, Inc.
|
42.44% | 0.926 | 18.08% | 1.25x |
|
XWEL
XWELL, Inc.
|
278.04% | 2.463 | 65.46% | 0.57x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ICLR
ICON plc
|
$456M | $258.9M | 4.57% | 6.29% | 12.67% | $351.9M |
|
FONR
FONAR Corp.
|
$9.7M | $3M | 4.84% | 6.02% | 11.74% | -$167K |
|
FUNI
Hypha Labs, Inc.
|
-$11.7K | -$475K | -28992.29% | -- | -- | -$150.2K |
|
IDXG
Interpace Biosciences, Inc.
|
$5.4M | $1.1M | 283.22% | -- | 13.08% | $1.8M |
|
TMO
Thermo Fisher Scientific, Inc.
|
$4.6B | $2.3B | 7.8% | 13.23% | 18.85% | $3B |
|
XWEL
XWELL, Inc.
|
$1.3M | -$282K | -84.75% | -224.93% | -3.84% | -$3.1M |
ICON plc vs. Competitors
-
Which has Higher Returns ICLR or FONR?
FONAR Corp. has a net margin of 0.12% compared to ICON plc's net margin of 9.94%. ICON plc's return on equity of 6.29% beat FONAR Corp.'s return on equity of 6.02%.
Company Gross Margin Earnings Per Share Invested Capital ICLRICON plc22.32% $0.03 $12.9B FONRFONAR Corp.37.95% $0.31 $202.7M -
What do Analysts Say About ICLR or FONR?
ICON plc has a consensus price target of $157.71, signalling upside risk potential of 58.19%. On the other hand FONAR Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that ICON plc has higher upside potential than FONAR Corp., analysts believe ICON plc is more attractive than FONAR Corp..
Company Buy Ratings Hold Ratings Sell Ratings ICLRICON plc7 9 0 FONRFONAR Corp.0 0 0 -
Is ICLR or FONR More Risky?
ICON plc has a beta of 1.270, which suggesting that the stock is 26.965% more volatile than S&P 500. In comparison FONAR Corp. has a beta of 1.002, suggesting its more volatile than the S&P 500 by 0.18499999999999%.
-
Which is a Better Dividend Stock ICLR or FONR?
ICON plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FONAR Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICON plc pays -- of its earnings as a dividend. FONAR Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or FONR?
ICON plc quarterly revenues are $2B, which are larger than FONAR Corp. quarterly revenues of $25.5M. ICON plc's net income of $2.4M is lower than FONAR Corp.'s net income of $2.5M. Notably, ICON plc's price-to-earnings ratio is 13.48x while FONAR Corp.'s PE ratio is 16.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICON plc is 0.99x versus 1.12x for FONAR Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRICON plc0.99x 13.48x $2B $2.4M FONRFONAR Corp.1.12x 16.52x $25.5M $2.5M
-
Which has Higher Returns ICLR or FUNI?
Hypha Labs, Inc. has a net margin of 0.12% compared to ICON plc's net margin of --. ICON plc's return on equity of 6.29% beat Hypha Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ICLRICON plc22.32% $0.03 $12.9B FUNIHypha Labs, Inc.-- -$0.00 -$601.6K -
What do Analysts Say About ICLR or FUNI?
ICON plc has a consensus price target of $157.71, signalling upside risk potential of 58.19%. On the other hand Hypha Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that ICON plc has higher upside potential than Hypha Labs, Inc., analysts believe ICON plc is more attractive than Hypha Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ICLRICON plc7 9 0 FUNIHypha Labs, Inc.0 0 0 -
Is ICLR or FUNI More Risky?
ICON plc has a beta of 1.270, which suggesting that the stock is 26.965% more volatile than S&P 500. In comparison Hypha Labs, Inc. has a beta of 1.232, suggesting its more volatile than the S&P 500 by 23.248%.
-
Which is a Better Dividend Stock ICLR or FUNI?
ICON plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hypha Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICON plc pays -- of its earnings as a dividend. Hypha Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or FUNI?
ICON plc quarterly revenues are $2B, which are larger than Hypha Labs, Inc. quarterly revenues of --. ICON plc's net income of $2.4M is higher than Hypha Labs, Inc.'s net income of -$521.6K. Notably, ICON plc's price-to-earnings ratio is 13.48x while Hypha Labs, Inc.'s PE ratio is 4.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICON plc is 0.99x versus 1.16x for Hypha Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRICON plc0.99x 13.48x $2B $2.4M FUNIHypha Labs, Inc.1.16x 4.88x -- -$521.6K
-
Which has Higher Returns ICLR or IDXG?
Interpace Biosciences, Inc. has a net margin of 0.12% compared to ICON plc's net margin of 11.55%. ICON plc's return on equity of 6.29% beat Interpace Biosciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ICLRICON plc22.32% $0.03 $12.9B IDXGInterpace Biosciences, Inc.62.12% $0.03 $2M -
What do Analysts Say About ICLR or IDXG?
ICON plc has a consensus price target of $157.71, signalling upside risk potential of 58.19%. On the other hand Interpace Biosciences, Inc. has an analysts' consensus of -- which suggests that it could grow by 494.6%. Given that Interpace Biosciences, Inc. has higher upside potential than ICON plc, analysts believe Interpace Biosciences, Inc. is more attractive than ICON plc.
Company Buy Ratings Hold Ratings Sell Ratings ICLRICON plc7 9 0 IDXGInterpace Biosciences, Inc.0 0 0 -
Is ICLR or IDXG More Risky?
ICON plc has a beta of 1.270, which suggesting that the stock is 26.965% more volatile than S&P 500. In comparison Interpace Biosciences, Inc. has a beta of 1.115, suggesting its more volatile than the S&P 500 by 11.457%.
-
Which is a Better Dividend Stock ICLR or IDXG?
ICON plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Interpace Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICON plc pays -- of its earnings as a dividend. Interpace Biosciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or IDXG?
ICON plc quarterly revenues are $2B, which are larger than Interpace Biosciences, Inc. quarterly revenues of $8.8M. ICON plc's net income of $2.4M is higher than Interpace Biosciences, Inc.'s net income of $1M. Notably, ICON plc's price-to-earnings ratio is 13.48x while Interpace Biosciences, Inc.'s PE ratio is 6.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICON plc is 0.99x versus 0.71x for Interpace Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRICON plc0.99x 13.48x $2B $2.4M IDXGInterpace Biosciences, Inc.0.71x 6.88x $8.8M $1M
-
Which has Higher Returns ICLR or TMO?
Thermo Fisher Scientific, Inc. has a net margin of 0.12% compared to ICON plc's net margin of 16.21%. ICON plc's return on equity of 6.29% beat Thermo Fisher Scientific, Inc.'s return on equity of 13.23%.
Company Gross Margin Earnings Per Share Invested Capital ICLRICON plc22.32% $0.03 $12.9B TMOThermo Fisher Scientific, Inc.37.95% $5.21 $92.9B -
What do Analysts Say About ICLR or TMO?
ICON plc has a consensus price target of $157.71, signalling upside risk potential of 58.19%. On the other hand Thermo Fisher Scientific, Inc. has an analysts' consensus of $666.46 which suggests that it could grow by 30.44%. Given that ICON plc has higher upside potential than Thermo Fisher Scientific, Inc., analysts believe ICON plc is more attractive than Thermo Fisher Scientific, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ICLRICON plc7 9 0 TMOThermo Fisher Scientific, Inc.17 5 0 -
Is ICLR or TMO More Risky?
ICON plc has a beta of 1.270, which suggesting that the stock is 26.965% more volatile than S&P 500. In comparison Thermo Fisher Scientific, Inc. has a beta of 0.928, suggesting its less volatile than the S&P 500 by 7.166%.
-
Which is a Better Dividend Stock ICLR or TMO?
ICON plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Thermo Fisher Scientific, Inc. offers a yield of 0.34% to investors and pays a quarterly dividend of $0.43 per share. ICON plc pays -- of its earnings as a dividend. Thermo Fisher Scientific, Inc. pays out 9.7% of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ICLR or TMO?
ICON plc quarterly revenues are $2B, which are smaller than Thermo Fisher Scientific, Inc. quarterly revenues of $12.2B. ICON plc's net income of $2.4M is lower than Thermo Fisher Scientific, Inc.'s net income of $2B. Notably, ICON plc's price-to-earnings ratio is 13.48x while Thermo Fisher Scientific, Inc.'s PE ratio is 28.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICON plc is 0.99x versus 4.33x for Thermo Fisher Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRICON plc0.99x 13.48x $2B $2.4M TMOThermo Fisher Scientific, Inc.4.33x 28.80x $12.2B $2B
-
Which has Higher Returns ICLR or XWEL?
XWELL, Inc. has a net margin of 0.12% compared to ICON plc's net margin of -2.87%. ICON plc's return on equity of 6.29% beat XWELL, Inc.'s return on equity of -224.93%.
Company Gross Margin Earnings Per Share Invested Capital ICLRICON plc22.32% $0.03 $12.9B XWELXWELL, Inc.17.32% -$0.26 $13M -
What do Analysts Say About ICLR or XWEL?
ICON plc has a consensus price target of $157.71, signalling upside risk potential of 58.19%. On the other hand XWELL, Inc. has an analysts' consensus of -- which suggests that it could grow by 1743.08%. Given that XWELL, Inc. has higher upside potential than ICON plc, analysts believe XWELL, Inc. is more attractive than ICON plc.
Company Buy Ratings Hold Ratings Sell Ratings ICLRICON plc7 9 0 XWELXWELL, Inc.0 0 0 -
Is ICLR or XWEL More Risky?
ICON plc has a beta of 1.270, which suggesting that the stock is 26.965% more volatile than S&P 500. In comparison XWELL, Inc. has a beta of 1.511, suggesting its more volatile than the S&P 500 by 51.09%.
-
Which is a Better Dividend Stock ICLR or XWEL?
ICON plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICON plc pays -- of its earnings as a dividend. XWELL, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or XWEL?
ICON plc quarterly revenues are $2B, which are larger than XWELL, Inc. quarterly revenues of $7.3M. ICON plc's net income of $2.4M is higher than XWELL, Inc.'s net income of -$211K. Notably, ICON plc's price-to-earnings ratio is 13.48x while XWELL, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICON plc is 0.99x versus 0.07x for XWELL, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRICON plc0.99x 13.48x $2B $2.4M XWELXWELL, Inc.0.07x -- $7.3M -$211K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
